300289 Beijing Leadman Biochemistry
- 4.21
- +0.12+2.93%
Beijing Leadman Biochemistry News
Leadman: Announcement on the acquisition of a medical device registration certificate by its subsidiary Desai Systems
Beijing Leadman Biochemistry: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Beijing Leadman Biochemistry: Announcement Regarding Write-Back of Asset Impairment Provision in the First Half of 2024.
Beijing Leadman Biochemistry: Interim report disclosure prompt announcement for 2024.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement on the Progress of Overseas Investment.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement regarding the signing of a supplementary agreement for the house rental contract by the company.
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement on the Progress of Entrusted Wealth Management with Idle Self-owned Funds
Beijing Leadman Biochemistry: Announcement regarding the signing of a supplementary agreement for the house rental contract by the company.
Beijing Leadman Biochemistry: Progress announcement on the use of idle own funds for delegated financial management
Beijing Leadman Biochemistry: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Beijing Leadman Biochemistry: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Beijing Leadman Biochemistry: 2024 First Quarter Report Disclosure Prompt Announcement
Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Progress announcement on the use of idle own funds for delegated financial management
Leadman: Corrections to the 2023 Accrued Asset Impairment Preparation
Leadman: Audit Committee Annual Report Work Procedure
Leadman: Report of the Board Audit Committee on the implementation of supervisory duties by accounting firms in 2023
Analysis
Price Target
No Data
